直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

At the PTAB Blog

Petitioner Estopped Due to Final Written Decisions in Parallel IPR Proceedings with Petitions Filed Simultaneously

February 15, 2022

Authored and Edited by Troy V Viger; Joshua L. Goldberg

In Intuitive Surgical, Inc. v. Ethicon LLC, No. 2020-1481 (Fed. Cir. Feb. 11, 2022), the Federal Circuit affirmed that Intuitive was estopped under § 315(e)(1) from maintaining an IPR and dismissed the appeal.

Intuitive simultaneously filed three IPRs challenging the patentability of Ethicon’s patent, each relying on different prior art references, yet each attacking the same claims. The Board issued final written decisions in two of the IPRs. Later, in the third, the Board removed Intuitive as a petitioner because § 315(e)(1) estopped Intuitive after issuance of the two final written decisions.

Intuitive argued § 315(e)(1) estoppel should not apply to simultaneously filed petitions. The Court rejected Intuitive’s argument that it could not “reasonably have raised” all its grounds in two IPR petitions because of word limits. The Federal Circuit also noted that Intuitive had alternative avenues that would have allowed it to file three full-length petitions while avoiding the consequences of § 315(e)(1). It could have sought consolidation or focused each petition on a separate set of claims.

Intuitive also argued it may appeal the Board’s decision because it was once a party to an IPR. The Federal Circuit concluded that once § 315(e)(1) estopped Intuitive, it ceased to be a party, and lost any right to appeal.

Tags

Patent Trial and Appeal Board (PTAB), IPR estoppel, Final Written Decision

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Related Industries

Life Sciences

Medical Device and Diagnostics

Related Offices

Atlanta, GA

Washington, DC

Contacts

Joshua L. Goldberg
Partner
Reston, VA
+1 202 408 6092
Email

Copyright © 2022 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

4th Global Patent Litigation FORUM

October 29, 2026

Munich

Hybrid Conference

Intellectual Property Law Institute 2026 – California

October 19-20, 2026

San Francisco

Hybrid Conference

Intellectual Property Law Institute 2026 – New York

September 28-29, 2026

New York

Lecture

Resolving Patent Suits Without Settlement Payments

September 3, 2026

Virtual

Conference

Finnegan IP Summit 2026: Celebrating an Inclusive Talent Pipeline

August 11-13, 2026

Washington, DC

Conference

13th Annual Summit for Women Leaders in Life Sciences Law

July 29-30, 2026

Boston

Webinar

U.S. Patent Case Law Update 2026

July 23, 2026

Webinar

Webinar

Successful Strategies to Win Alice Motions and Fee Awards in Patent Cases Against Non-Practicing Entities

July 22, 2026

Webinar

Conference

2026 China Pharmaceutical Innovation Conference

July 22-24, 2026

Shanghai

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP